DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



More Industry Headlines

Radiologists trail only primary care in number of diagnosis-related lawsuits Study says incidental findings pose a “major problem”

Guerbet teams with Imalogix to enhance dose management Utilizes Imalogix's AI-based process and workflow solutions

The MITA narrative on third-party equipment service lacks merit: ACCE A response to Patrick Hope's editorial calling for greater regulation

NYU offers full-tuition scholarships to new, current med students Only offer of its kind in the top 10 U.S. med schools

Beyond silver, gold and platinum: How OEM service is getting more customized Manufacturers aim to give providers everything they want, nothing more

Healthix adopts Verato solution for patient matching, waives HIE connection fee Largest public health information exchange in the US

Study: AI detects neurological issues on CT scans in under two seconds 150 times shorter than average reading time of a physician

Philips partners with Intel on CPU efficiency for medical imaging use cases Pairs Philips' OpenVINO toolkit with Intel Xeon Scalable processors

Elevating HTM out of the basement Seven tips to demonstrate the value of your team to the organization

Tech giants sign on to interoperability pledge Amazon, Google, IBM, Microsoft, Oracle, and Salesforce agree to common interest

Could save firms millions

FDA proposing new fast track for medical device approval

by Thomas Dworetzky , Contributing Reporter
The U.S. Food and Drug Administration is proposing a “fast track” for certain medical devices, as well as cuts to the safety data needed for agency approval.

It is the agency's “intention to propose an alternate approach to the traditional 510(k) clearance process, which will involve the use of modern, science-based, consensus standards and FDA-developed performance criteria as the comparator for device review for certain well-understood technologies,” FDA commissioner Dr. Scott Gottlieb wrote in the official FDA blog.

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

At present, he pointed out, the agency compares new devices to prior ones, called predicates, that can be as much as 40 years old. In order for a new device to gain 510(k) clearance it must have moderate risk and be “substantially equivalent” to one that already exists.

Basically, the new alternative to predicates makes them replaceable by a different approach that uses benchmarks of performance standards and guidance documents — the plan, according to Reuters, would be voluntary.

“Today, in new draft guidance on the Least Burdensome Provisions, FDA defines least burdensome to be the 'minimum amount of information necessary to adequately address a regulatory question or issue through the most efficient manner at the right time.' The new draft guidance also explains FDA’s regulatory approach and delineates guiding principles that we propose to apply across the total product life cycle — beyond what Congress has required — including all device-related applications and interactions with the medical device industry,” Gottlieb wrote in the agency blog post.

The alternative path could save firms millions of dollars and save substantial time in bringing new products to market.

The approach also supports President Trump's call to slash regulations and has garnered support from makers.

Industry group AdvaMed “commends FDA’s commitment to promoting patient access to medical technologies through innovative regulatory pathways,” its spokeswoman Janet Trunzo told Reuters.

Gottlieb also addressed the issue of high-risk products and stated that the agency would look to speed up their approval as well — and plans to issue new guidance that will lay out “how certain issues could be ultimately resolved in the postmarket setting, rather than the premarket setting, to allow patients to gain faster access to potentially lifesaving devices.”

Dr. Rita Redberg, a cardiologist at the University of California San Francisco and editor of JAMA Internal Medicine, raised concerns to the news agency, however, arguing that the moves could put safety issues from premarket to postmarket — and possibly risk patients' health.

“When we use devices on patients without clinical studies first, the patients effectively become the trial and the insurers become the funder of the device trial,” she advised.

Others in the health care community also chimed in about the potential easing of premarket testing.

“I see a potentially huge problem in moving more risk to the post-approval setting,” said Areta Kupchyk, a partner at Foley Hoag and former associate chief counsel at the FDA. “It’s very difficult once a product has been approved to pull it back.”


You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.